News | December 11, 2008

Siemens’ IQ•SPECT Technology Nets FDA Clearance

December 12, 2008 – IQ•SPECT is the newest Symbia feature from Siemens Healthcare that reportedly enables a comprehensive cardiac evaluation including perfusion, attenuation correction and calcium scoring in just five minutes.

Achieved with SMARTZOOM collimators that magnify the heart while imaging the rest of the torso under traditional conditions, IQ•SPECT technology combines this cardio-centric orbit acquisition technique with fast, 3D iterative reconstruction to enable more confident diagnoses and improved patient comfort, enhancing image quality, speed, productivity and throughput.

IQ•SPECT is 510k-cleared and commercially available on all Symbia S and T systems, and is field upgradeable for any existing systems.

For more information:

Related Content

Siemens Healthineers, Symbia Intevo SPECT/CT system, xSPECT Quant, RSNA 2016
Technology | SPECT-CT | October 18, 2016
At the 2016 annual meeting of the Radiological Society of North America (RSNA 2016), Siemens Healthineers will showcase...
GE Healthcare, general purpose digital SPECT/CT, Discovery NM/CT 670 CZT, Barnes-Jewish Hospital, first U.S. install
News | SPECT-CT | May 05, 2016
Doctors and researchers at Barnes-Jewish Hospital and Washington University in St. Louis may be able to better diagnose...